Exemestane 25 - British Dragon

Exemestane is a potent irreversible aromatase inhibitor classified as steroidal, contrasting with nonsteroidal agents like anastrozole. Developed by Pharmacia and launched under the brand Aromasin, it was approved in the U.S. in 1999 and marketed from 2000. It was created to treat postmenopausal breast cancer patients who relapsed after tamoxifen. It suppresses estrogen by up to 85%, making it effective not only in oncology but also in bodybuilding where it helps prevent estrogen-linked side effects of steroid use.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Exemestane 25 by British Dragon, consult with your doctor or healthcare professional.